Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000128

Options or other derivatives

  • Exec VP, Comm Optns acquired 373,033 shares (grant or award)
  • Exec VP, Comm Optns returned 373,033 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
BOYER ANDREW S Exec VP, Comm Optns 2019-11-13 Returned to the company · Stock Option −272,480 0 D
BOYER ANDREW S Exec VP, Comm Optns 2019-11-13 Grant or award · Stock Option +272,480 272,480 D
BOYER ANDREW S Exec VP, Comm Optns 2019-11-13 Returned to the company · Stock Option −100,553 0 D
BOYER ANDREW S Exec VP, Comm Optns 2019-11-13 Grant or award · Stock Option +100,553 100,553 D
Loading xslF345X03/wf-form4_157377037285700.xml…